Mdm2 and HIF-1α interaction in tumor cells during hypoxia

Journal of Cellular Physiology

Volumn 204, Issue 2, 2005, Pages 364-369

  Nieminen, Anna Liisa ^a,c   Qanungo, Suparna ^a   Schneider, Elizabeth A ^a   Jiang, Bing Hua ^b   Agani, Faton H ^a,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d 322 Biomedical Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN MDM2; PROTEIN P53; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; MDM2 PROTEIN, HUMAN; MDM2 PROTEIN, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TUMOR CELL; ANIMAL; ANOXIA; CELL CULTURE; CELL HYPOXIA; DRUG INTERACTION; GENETICS; METABOLISM; MOUSE; NEOPLASM; TRANSACTIVATION;

ANIMALS; ANOXIA; CELL HYPOXIA; CELLS, CULTURED; DRUG INTERACTIONS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NEOPLASMS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 21644470214     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20406     Document Type: Article

References (21)

1. Alarcon R, Koumenis C, Geyer RK, Maki CG, Giaccia AJ. 1999. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res 59:6046-6051.
2. Alarcon-Vargas D, Ronai Z. 2002. p53-Mdm2 - the affair that never ends. Carcinogenesis 23:541-547.
3. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. 1998. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392:405-408.
4. Ashcroft M, Vousden KH. 1999. Regulation of p53 stability. Oncogene 18:7637-7643.
5. Bardos JI, Chau NM, Ashcroft M. 2004. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression. Mol Cell Biol 24:2905-2914.
6. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L. 1998. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273:11995-11998.
7. Chen D, Li M, Luo J, Gu W. 2003. Direct interactions between HIF-1alpha and Mdm2 modulate p53 Function. J Biol Chem 278:13595-13598.
8. Forsythe JA, Jiang BH, Iyer NV, et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
9. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS. 2003. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 23:359-369.
10. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Jr., Giaccia AJ. 1994. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14:6264-6277.
11. Graeber TG, Osmanian C, Jacks T, et al. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91.
12. Hansson LO, Friedler A, Freund S, Rudiger S, Fersht AR. 2002. Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci USA 99:10305-10309.
13. Honda R, Tanaka H, Yasuda H. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420:25-27.
14. Koumenis C, Alarcon R, Hammond E, et al. 2001. Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 21:1297-1310.
15. McMasters KM, Montes de Oca LR, Pena JR, Lozano G. 1996. Mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts. Oncogene 13:1731-1736.
16. Meplan C, Richard MJ, Hainaut P. 2000. Metalloregulation of the tumor suppressor protein p53: Zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19:5227-5236.
17. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860.
18. Ravi R, Mookerjee B, Bhujwalla ZM, et al. 2000. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14:34-44.
19. Safran M, Kaelin WG Jr. 2003. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest 111:779-783.
20. Wang GL, Semenza GL. 1995. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270:1230-1237.
21. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. 2003. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem 278:15911-15916.